Prasanth Viswanathan

Researcher

University of Arkansas for Medical Sciences

unknown

1 h-index 4 pubs 2 cited

Research Areas

Cancer-related molecular mechanisms research Mitochondrial Function and Pathology Lymphoma Diagnosis and Treatment Metabolism and Genetic Disorders Multiple Myeloma Research and Treatments Immune Response and Inflammation Protein Structure and Dynamics

Links

Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Prasanth Viswanathan's research investigates the molecular mechanisms underlying cancer cell survival and death, with a particular focus on hematological malignancies. His work has explored the role of anti-apoptotic BCL2 family members, such as MCL1, in dictating the selective addiction of Kaposi’s sarcoma-associated herpesvirus-transformed primary effusion lymphoma cell lines. Viswanathan has also studied the mitochondrial ubiquitin ligase MARCHF5 and its cooperative role with MCL1 in inhibiting apoptosis in these cell lines. More recently, his research has extended to the metabolic changes and ferroptosis induction caused by the suppression of TRIP13 in multiple myeloma. Viswanathan has authored four publications and collaborates with researchers at the University of Arkansas for Medical Sciences, including Mark Manzano, Daniel Dunham, and Jackson Gill.

Metrics

  • h-index: 1
  • Publications: 4
  • Citations: 2

Selected Publications

  • The Mitochondrial Ubiquitin Ligase MARCHF5 Cooperates with MCL1 to Inhibit Apoptosis in KSHV-Transformed Primary Effusion Lymphoma Cell Lines (2024) DOI
  • Suppression of TRIP13 Induces Metabolic Changes and Potentiates Ferroptosis in Multiple Myeloma (2023) DOI
  • Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi’s Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1 (2022) DOI
  • Expression Ratios of the Anti-Apoptotic BCL2 Family Members Dictate the Selective Addiction of KSHV-Transformed Primary Effusion Lymphoma Cell Lines to MCL1 (2022) DOI

Collaborators

Researchers in the database who share publications

Mark Manzano University of Arkansas for Medical Sciences 4 shared publications Daniel Dunham University of Arkansas for Medical Sciences 3 shared publications Jackson Gill University of Arkansas for Medical Sciences 3 shared publications Fumou Sun University of Arkansas for Medical Sciences 1 shared publication

Similar Researchers

Based on overlapping research topics

Daniel Dunham University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Mitochondrial Function and Pathology Immune Response and Inflammation
Good match 4 shared topics
Jackson Gill University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Mitochondrial Function and Pathology Immune Response and Inflammation
Good match 4 shared topics
Wen Ling University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Mitochondrial Function and Pathology Multiple Myeloma Research and Treatments
Good match 4 shared topics
Harrison Brown University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Mitochondrial Function and Pathology Metabolism and Genetic Disorders
Good match 4 shared topics
Runa Shrestha University of Arkansas – Fort Smith
Cancer-related molecular mechanisms research Lymphoma Diagnosis and Treatment Multiple Myeloma Research and Treatments
Good match 3 shared topics
Cody Ashby University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Multiple Myeloma Research and Treatments Immune Response and Inflammation
Good match 4 shared topics